How our Company Increases Efforts in Electrophysiology
We are pleased to share the latest interview with Eric Michaels of eHealth Radio Network, which includes a discussion of BioSig’s mission, recent strides in electrophysiology, and the future of bioelectronic medicine. The interview allowed us to share our Company’s story—beginning as an idea on a piece of paper and evolving into a world-class team of medical technology professionals united by the shared goal of transforming healthcare.
BioSig’s mission is first and foremost to solve an unmet need in the treatment of arrhythmias. As we penetrate the global electrophysiology market, projected to reach $12.2 billion by 2026, BioSig is unwavering in its commitment to reshaping the future of cardiovascular health. Toward that end, our first product, the PURE EP™ system, is designed to help physicians understand and locate electrical interference in the heart by eliminating distortion in the signals emitted by the heart. Having commenced commercialization and sales efforts, BioSig is poised to become a key player in a rapidly growing industry.
As we enter the new calendar year, I could not be more proud of what our team has accomplished and the bright future that lies ahead. Thank you to everyone who has supported us along our journey and a special thanks to eHealth Radio for taking the time to speak with us.
All the best,
Kenneth L. Londoner
Chairman & CEO, BioSig Technologies, Inc.